In this section you can read all the latest news about counterfeit and substandard medicines from around Europe and the world.
Event summary of “Nanomedicines and nanosimilars: the medical need for a centralised EMA regulatory process” held as a live webinar on 30th November 2021 10.00-11.30
PRESS RELEASE: Nanomedicines and nanosimilars: the medical need for a centralised EMA regulatory process
Nanomedicines enhance the way that medicines target and reach areas of disease within the body, opening up new therapeutic options. They offer potential solutions for
EVENT: Nanomedicines and nanosimilars: the medical need for a centralised EMA regulatory process – 30 November 2021 – 10:00 to 11:30 CET
On behalf of the European Alliance for Access to Safe Medicines, you are kindly invited to join the upcoming virtual roundtable event on “Nanomedicines and
PRESS RELEASE: ASOP EU gains official “Observer” status at the Medicrime Convention Committee of the Parties
At the 4th plenary session of the Medicrime Committee of the Parties (CoP) the Alliance for Safe Online Pharmacy in the EU (ASOP EU) was voted in and